india-diabetes-devices-market
Published

OCT 2018

India Diabetes Devices Market - Growth, Trends, and Forecasts (2018 - 2023)

Purchase Report
$3000
Single user license
$3500
Team license
$6500
Corporate license

India holds the second largest market in the diabetes care device market after china in asia pacific region because of the high diabetes population in the country and diabetes population is also expected to reach 84.1 million in 2023 in India.

The Indian diabetes devices market has been estimated at USD 2.12 billion in 2017, growing at a CAGR of 1.8% during the forecast period from 2018 to 2023. Diabetes care devices are the devices used to control the glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. The continuous glucose monitoring devices are increasingly widely used due to innovations and technological innovations.

Diabetes is growing at an alarming rate in India, home to more than 65.1 million people with the disease, compared to 50.8 million in 2010. One main reason for the rise in the diabetic population is obesity. Obesity is reaching epidemic proportions among India's middle-class children and adolescents, as young people choose western fast food over traditional cuisine. 

The Insulin infusion Pump segment is expected to witness the highest CAGR of 4.7% in the forecast period because it offer highest convenience among all the insulin delivery devices. The intergrated insulin pump is expected to boost the market because it offer the management and monitoring the blood glucose level real time. However slow acceptance of insulin pump is because of the high cost associated with the pump and its disposables.

Key Players:

Abbott Diabetes Care, Roche, Johnson & Johnson, Arkray, Ascensia Diabetes Care, AgaMatrix, LifeScan, Sanofi, Dexcom, Medtronic, Ypsomed, Novo Nordisk, Eli Lilly.

Key Developments:  

Nov 2017: Roche has Almost 48 percent share in blood glucose monitoring market in India and it is aiming to reach 51 percent by 2019 as per the Roche India MD Sidhartha Roy.

Report Scope:

Attribute

Details

Base year for estimation

2017

Review Period

2012-2017

Forecast Period

2018 – 2023

Market Representation

Revenue in USD billion and CAGR from 2018 – 2023

Regions covered

India

Report coverage

Revenue forecast, market share analysis, and market dynamics

 

Reasons to Purchase this Report:

  • To study current and future market outlook in the India market
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Detailed analysis of the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identifying the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet in excel

Report Customization and Benefits:

This report can be customized to meet the desired requirements. Please connect with our analyst, who will ensure that you get a report that suits your needs.

 

 

Diabetes Devices Intelligence Center

Covering 3 categories, 8 segments across 25 countries - offering over 8,600 data points

Our Clients Include View All

Looking to Customize Report?